TGFBR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.276150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.790200E-01
Normal-vs-Stage2
1.508410E-01
Normal-vs-Stage3
6.975900E-02
Normal-vs-Stage4
5.177600E-01
Stage1-vs-Stage2
6.707000E-01
Stage1-vs-Stage3
4.024400E-01
Stage1-vs-Stage4
5.184400E-01
Stage2-vs-Stage3
1.488030E-01
Stage2-vs-Stage4
5.742000E-01
Stage3-vs-Stage4
6.204000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.086950E-01
Normal-vs-AfricanAmerican
4.172400E-01
Normal-vs-Asian
2.747400E-01
Caucasian-vs-AfricanAmerican
6.698400E-01
Caucasian-vs-Asian
7.822200E-01
AfricanAmerican-vs-Asian
8.750400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.822440E-01
Normal-vs-Female
8.430300E-02
Male-vs-Female
6.673400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.987790E-01
Normal-vs-Age(41-60Yrs)
1.837970E-01
Normal-vs-Age(61-80Yrs)
1.584640E-01
Normal-vs-Age(81-100Yrs)
2.277400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.432200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.890600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.722600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.298200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.603560E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.189920E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.349600E-02
Normal-vs-Daily Drinker
9.412000E-02
Normal-vs-Weekly Drinker
2.612400E-01
Normal-vs-Occasional Drinker
6.425700E-02
Normal-vs-Social Drinker
5.914600E-01
Non Drinker-vs-Daily Drinker
9.216400E-01
Non Drinker-vs-Weekly Drinker
1.269570E-01
Non Drinker-vs-Occasional Drinker
8.361600E-01
Non Drinker-vs-Social Drinker
5.750000E-02
Daily Drinker-vs-Weekly Drinker
2.605400E-01
Daily Drinker-vs-Occasional Drinker
9.355600E-01
Daily Drinker-vs-Social Drinker
7.504200E-02
Weekly Drinker-vs-Occasional Drinker
2.586200E-01
Weekly Drinker-vs-Social Drinker
4.734600E-01
Occasional Drinker-vs-Social Drinker
7.975700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.481600E-01
Normal-vs-Grade 2
1.404980E-01
Normal-vs-Grade 3
2.046200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.599200E-01
Grade 1-vs-Grade 3
7.672400E-01
Grade 1-vs-Grade 4
3.481600E-01
Grade 2-vs-Grade 3
6.314200E-01
Grade 2-vs-Grade 4
1.404980E-01
Grade 3-vs-Grade 4
2.046200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.249380E-01
Normal-vs-NonDiabetic
9.324400E-02
Diabetic-vs-NonDiabetic
4.228800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.633400E-01
Normal-vs-NoPancreatitis
8.944500E-02
Pancreatitis-vs-NoPancreatitis
8.316000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.064600E-01
Normal-vs-N1
1.435230E-01
N0-vs-N1
2.534000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.997630E-01
Normal-vs-TP53-NonMutant
1.128650E-01
TP53-Mutant-vs-TP53-NonMutant
5.580400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
